Health Care: Drugs

Idexx Laboratories (IDXX: NASDAQ)

$83.81 -0.67 | -0.79%
05/24/13 - 12:50 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 1.29B 1.22B 1.10B 1.03B
Cost of Sales 541.78M 523.98M 478.81M 455.58M
Gross Operating Profit 751.56M 694.71M 624.58M 576.05M
Selling, General, and Administrative Expenses 354.57M 334.24M 306.14M 285.19M
Research & Development 82.01M 76.04M 68.60M 65.12M
Operating Income before D & A (EBITDA) 314.97M 284.43M 249.84M 225.74M
Depreciation & Amortization 52.41M 48.20M 45.96M 49.77M
Interest Income 1.90M 1.74M 663.00K 486.00K
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 264.46M 237.97M 204.54M 176.46M
Interest Expense 3.85M 3.55M 2.42M 1.92M
Pre-Tax Income 260.62M 234.42M 202.13M 174.54M
Income Taxes 82.33M 72.67M 60.81M 52.30M
Minority Interest 20.00K -32.00K 36.00K 10.00K
Net Income From Continuing Operations 178.29M 161.79M 141.28M 122.22M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 178.29M 161.79M 141.28M 122.22M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 178.27M 161.79M 141.28M 122.22M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 178.29M 161.79M 141.28M 122.22M
Preferred Dividends
Net Income Available To Common 178.29M 161.79M 141.28M 122.22M
Basic EPS from Continuing Ops. 3.24 2.85 2.45 2.08
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 3.24 2.85 2.45 2.08
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 3.24 2.85 2.45 2.08
Basic Normalized Net Income/Share 3.24 2.85 2.45 2.08
EPS fr Continuing Ops. 3.17 2.78 2.37 2.01
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 3.17 2.78 2.37 2.01
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 3.17 2.78 2.37 2.01
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 3.17 2.78 2.37 2.01
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with IDXX

View All

Latest IDXX Headlines from TheStreet

More Financial News for IDXX

Press Releases for IDXX

See All Press Releases

Partner Headlines for IDXX

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter